Insider Trading Summary for Sangamo Biosciences Inc. (SGMO): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Jun-23 4:51 PM View:	01-Jun-23 Grant 0	Parker H Stewart Director		Sangamo Biosciences Inc. - SGMO	29% 48.7K to 62.6K	0	0	--	--	Show Txns Hide Txns

05-Jun-23 4:47 PM View:	01-Jun-23 Grant 0	Carey Robert Director		Sangamo Biosciences Inc. - SGMO	39% 35.7K to 49.6K	0	0	--	--	Show Txns Hide Txns

05-Jun-23 4:52 PM View:	01-Jun-23 Grant 0	Smith Karen L. Director		Sangamo Biosciences Inc. - SGMO	36% 38.2K to 52.1K	0	0	--	--	Show Txns Hide Txns

30-May-23 4:44 PM View:	25-May-23 Payment of Exercise ($2.33K)	Ramelmeier Rolf Andrew EVP, Technical Operations		Sangamo Biosciences Inc. - SGMO	(1%) 173.22K to 171.47K	0	0	--	--	Show Txns Hide Txns

05-Jun-23 4:50 PM View:	01-Jun-23 Grant 0	Meyers James R Director		Sangamo Biosciences Inc. - SGMO	39% 35.7K to 49.6K	0	0	--	--	Show Txns Hide Txns

05-Jun-23 4:49 PM View:	01-Jun-23 Grant 0	Markels John Director		Sangamo Biosciences Inc. - SGMO	43% 32.48K to 46.38K	0	0	--	--	Show Txns Hide Txns

28-Sep-23 5:30 PM View:	26-Sep-23 Sale ($3.00M)	Biogen Idec Inc 10% Owner		Sangamo Biosciences Inc. - SGMO	(25%) 23.65M to 17.65M	0	0	--	--	Show Txns Hide Txns

05-Jun-23 4:48 PM View:	01-Jun-23 Grant 0	Hillan Kenneth Director		Sangamo Biosciences Inc. - SGMO	39% 35.7K to 49.6K	0	0	--	--	Show Txns Hide Txns

28-Nov-23 4:18 PM View:	25-Nov-23 Payment of Exercise ($0.39K)	Fontenot Jason D. SVP, Chief Scientific Officer		Sangamo Biosciences Inc. - SGMO	(2%) 139.36K to 136.27K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:13 PM View:	25-Feb-24 Payment of Exercise ($3.90K)	Willoughby Scott B. SVP, Gen. Counsel & Secretary		Sangamo Biosciences Inc. - SGMO	561% 126.61K to 836.43K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:11 PM View:	25-Feb-24 Payment of Exercise ($27.30K)	MacRae Sandy President, CEO and Director Director		Sangamo Biosciences Inc. - SGMO	309% 623.71K to 2.55M	0	0	--	--	Show Txns Hide Txns

28-Nov-23 4:19 PM View:	25-Nov-23 Payment of Exercise ($0.74K)	McClung David Mark EVP, Chief Operating Officer		Sangamo Biosciences Inc. - SGMO	(5%) 224.77K to 212.47K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:12 PM View:	25-Feb-24 Payment of Exercise ($3.90K)	Duraibabu Prathyusha SVP, Chief Financial Officer		Sangamo Biosciences Inc. - SGMO	526% 133.38K to 834.58K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:13 PM View:	25-Feb-24 Payment of Exercise ($5.66K)	Dubois-Stringfellow Nathalie SVP-Chief Development Officer		Sangamo Biosciences Inc. - SGMO	511% 138.56K to 846.19K	0	0	--	--	Show Txns Hide Txns

05-Jun-23 4:48 PM View:	01-Jun-23 Grant 0	Horn Margaret A Director		Sangamo Biosciences Inc. - SGMO	74% 18.75K to 32.65K	0	0	--	--	Show Txns Hide Txns

05-Jun-23 4:46 PM View:	01-Jun-23 Grant 0	Beers Courtney Director		Sangamo Biosciences Inc. - SGMO	74% 18.75K to 32.65K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:14 PM View:	25-Feb-24 Payment of Exercise ($2.78K)	Pooler Amy VP, Head of Research		Sangamo Biosciences Inc. - SGMO	281% 51.47K to 196.31K	0	0	--	--	Show Txns Hide Txns

Sangamo Biosciences Inc. (SGMO)

Last Year

01-May-23 -- 30-Apr-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

01-May-22 -- 30-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--